tiprankstipranks
Supernus Pharmaceuticals (DE:S49)
NASDAQ:S49
Germany Market

Supernus Pharmaceuticals (S49) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Supernus Pharmaceuticals’s (S49) Moving Averages Convergence Divergence (MACD) indicator is -1.19, suggesting Supernus Pharmaceuticals is a Buy.
Supernus Pharmaceuticals’s (S49) 20-Day exponential moving average is 40.23, while Supernus Pharmaceuticals’s (S49) share price is €41.6, making it a Sell.
Supernus Pharmaceuticals’s (S49) 50-Day exponential moving average is 41.57, while Supernus Pharmaceuticals’s (S49) share price is €41.6, making it a Sell.

Supernus Pharmaceuticals (S49) Pivot Points

Jun 10, 2026, 07:40 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
38.20
38.20
38.20
38.20
38.20
38.20
38.20
Fibonacci
38.20
38.20
38.20
38.20
38.20
38.20
38.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Supernus Pharmaceuticals (S49) Moving Averages

Jun 10, 2026, 07:40 AM
Period
Simple
Exponential
MA5
38.16Buy
38.53Buy
MA10
39.28Sell
39.20Sell
MA20
40.78Sell
40.23Sell
MA50
42.06Sell
41.57Sell
MA100
42.73Sell
41.80Sell
MA200
41.80Sell
39.92Sell
Supernus Pharmaceuticals’s (S49) 10-Day exponential moving average is 39.20, while Supernus Pharmaceuticals’s (S49) share price is €41.6, making it a Sell.
Supernus Pharmaceuticals’s (S49) 100-Day exponential moving average is 41.80, while Supernus Pharmaceuticals’s (S49) share price is €41.6, making it a Sell.
Supernus Pharmaceuticals’s (S49) stock price is €41.6 and Supernus Pharmaceuticals’s (S49) 50-day simple moving average is 42.06, creating a Sell signal.
Supernus Pharmaceuticals’s (S49) stock price is €41.6 and Supernus Pharmaceuticals’s (S49) 100-day simple moving average is 42.73, creating a Sell signal.
Supernus Pharmaceuticals’s (S49) stock price is €41.6 and Supernus Pharmaceuticals’s (S49) 200-day simple moving average is 41.80, creating a Sell signal.

Supernus Pharmaceuticals (S49) Technical Indicators

Jun 10, 2026, 07:40 AM
Name
Value
Implied Action
RSI (14)
37.14
Neutral
STOCH (9,6)
12.59
Buy
STOCHRSI (14)
8.70
Buy
MACD (12,26)
-1.19
Buy
ADX (14)
19.23
Buy
Williams %R
-82.61
Buy
CCI (14)
-92.92
Neutral
ATR (14)
0.63
-
Ultimate Oscillator
31.63
Neutral
ROC
-6.76
Sell
Supernus Pharmaceuticals’s (S49) Relative Strength Index (RSI) is 37.14, creating a Neutral signal.
Supernus Pharmaceuticals’s (S49) Trend Strength Indicator (ADX) is 19.23, creating a Buy signal.
Supernus Pharmaceuticals’s (S49) Commodity Channel Index (CCI) is -92.92, creating a Neutral signal.
Supernus Pharmaceuticals’s (S49) Price Rate of Change (ROC) is -6.76, creating a Sell signal.

FAQ

Is S49 a Buy, Hold, or Sell?
Based on S49’s technical indicators, S49 is a Sell.
    What is S49’s RSI (14)?
    S49’s RSI (14) is 37.14, which suggests S49 is a Neutral.
      What is S49’s MACD?
      S49’s MACD is -1.19, which suggests S49 is a Buy.
        What is S49’s 5-day moving average?
        S49’s 5-day moving average is 38.16, which suggests S49 is a Buy.
          What is S49’s 20-day moving average?
          S49 20-day moving average is 40.78, which suggests S49 is a Sell.
            What is S49’s 50-day moving average?
            S49’s 50-day moving average is 42.06, which suggests S49 is a Sell.
              What is S49’s 200-day moving average?
              S49’s 200-day moving average is 41.80, which suggests S49 is a Sell.
                What is S49’s Williams % R (14)?
                S49’s Williams % R (14) is -82.61, which suggests S49 is a Buy.
                  What is S49’s CCI (14)?
                  S49’s CCI (14) is -92.92, which suggests S49 is a Neutral.
                    What is the share price of Supernus Pharmaceuticals?